Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 03:02PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.36 Insider Own49.55% Shs Outstand6.46M Perf Week-26.26%
Market Cap6.63M Forward P/E- EPS next Y-2.62 Insider Trans1.68% Shs Float3.26M Perf Month-60.32%
Income-15.37M PEG- EPS next Q-0.68 Inst Own6.46% Short Float / Ratio1.20% / 0.37 Perf Quarter-75.58%
Sales0.00M P/S- EPS this Y-13.33% Inst Trans- Short Interest0.04M Perf Half Y-89.33%
Book/sh-0.02 P/B- EPS next Y-2.94% ROA-207.15% Target Price56.25 Perf Year-94.44%
Cash/sh0.26 P/C3.90 EPS next 5Y- ROE-277.69% 52W Range0.96 - 18.60 Perf YTD-87.90%
Dividend- P/FCF- EPS past 5Y-69.45% ROI- 52W High-94.49% Beta-0.19
Dividend %- Quick Ratio0.88 Sales past 5Y0.00% Gross Margin- 52W Low6.74% ATR0.24
Employees4 Current Ratio0.88 Sales Q/Q- Oper. Margin0.00% RSI (14)27.22 Volatility22.55% 15.95%
OptionableNo Debt/Eq- EPS Q/Q-15.02% Profit Margin- Rel Volume0.88 Prev Close1.00
ShortableYes LT Debt/Eq- EarningsJul 27 AMC Payout- Avg Volume104.70K Price1.02
Recom1.00 SMA20-31.12% SMA50-59.17% SMA200-83.34% Volume79,834 Change2.50%
Date Action Analyst Rating Change Price Target Change
Oct-01-21Initiated Ascendiant Capital Markets Buy $8
Nov-20-23 08:00AM
Nov-16-23 08:00AM
Nov-13-23 08:00AM
Oct-30-23 08:00AM
Oct-23-23 09:31AM
08:00AM Loading…
Oct-02-23 09:30AM
Sep-22-23 08:00AM
Aug-30-23 09:30AM
Jun-22-23 09:30AM
Jun-13-23 08:00AM
May-24-23 08:00AM
12:38PM Loading…
May-11-23 12:38PM
Apr-04-23 06:30AM
Apr-03-23 09:35AM
Mar-22-23 09:30AM
Mar-17-23 07:09AM
Mar-16-23 08:00AM
Jan-26-23 08:00AM
Jan-04-23 08:00AM
Dec-28-22 08:00AM
Dec-13-22 03:52PM
Nov-22-22 08:05AM
08:00AM Loading…
Nov-15-22 08:00AM
Oct-31-22 08:00AM
Oct-11-22 10:03AM
Oct-05-22 12:45PM
Sep-29-22 12:29PM
Sep-22-22 08:00AM
Aug-25-22 07:13AM
Jul-24-22 08:41AM
Jul-18-22 10:42AM
Jun-20-22 09:22AM
Jun-03-22 08:00AM
May-17-22 08:00AM
May-06-22 09:02AM
May-05-22 08:00AM
May-04-22 06:25AM
Apr-28-22 06:30AM
Apr-11-22 08:00AM
Apr-06-22 10:15AM
Apr-04-22 08:00AM
Mar-28-22 08:00AM
Mar-18-22 06:31AM
Jan-13-22 04:00AM
Dec-17-21 09:54AM
Dec-14-21 06:35PM
Nov-30-21 08:30AM
Nov-11-21 07:17AM
Oct-01-21 09:24AM
Sep-30-21 01:45PM
Sep-16-21 06:09AM
Sep-15-21 06:29AM
Sep-13-21 06:30AM
Aug-17-21 10:59AM
Aug-04-21 06:30AM
Jul-30-21 06:30AM
Jul-28-21 03:07PM
Jul-26-21 04:03PM
Jul-23-21 12:44PM
Jul-12-21 06:00AM
Jul-01-21 06:45AM
Jun-28-21 03:59PM
Jun-17-21 04:30PM
Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company, which focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Katzoff David JChief Financial OfficerSep 26Buy0.1953,00010,23481,000Sep 26 06:01 PM
AULT MILTON C III10% OwnerMay 24Buy0.5918,00010,705383,000May 26 09:30 PM
Jackman StephanChief Executive OfficerApr 28Buy0.5437,00019,99845,500May 02 04:30 PM
McGrath Lynne FaheyDirectorMar 22Buy0.4310,0004,35010,000Mar 23 04:30 PM
AULT MILTON C III10% OwnerMar 17Buy0.435,0002,14911,060,001Mar 20 04:30 PM
AULT MILTON C III10% OwnerMar 16Buy0.504,0002,00611,055,001Mar 20 04:30 PM
Horne William B.DirectorFeb 24Option Exercise0.00500,0002,0001,000,000Feb 28 04:30 PM
AULT MILTON C III10% OwnerFeb 15Buy0.601,00059711,051,001Feb 17 09:55 PM
AULT MILTON C III10% OwnerDec 28Buy0.563,1001,74511,050,001Dec 29 06:00 AM
AULT MILTON C III10% OwnerDec 27Buy0.5990053211,046,901Dec 29 06:00 AM
AULT MILTON C III10% OwnerDec 21Buy0.815,0004,04911,046,001Dec 23 04:30 PM
AULT MILTON C III10% OwnerDec 19Buy0.8223,00018,81311,041,001Dec 20 04:30 PM
AULT MILTON C III10% OwnerDec 16Buy0.9020,00017,960345,000Dec 20 04:30 PM